+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anatomic Pathology Testing Market - Global Forecast 2026-2032- Product Image
Anatomic Pathology Testing Market - Global Forecast 2026-2032- Product Image
New

Anatomic Pathology Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904684
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Anatomic pathology testing is undergoing rapid change as new digital, molecular, and workflow technologies reshape diagnostic operations. Senior decision-makers are tasked with steering their organizations through this transformation to deliver better patient outcomes, improve operational flexibility, and ensure resilient supply chains in a competitive global environment.

Market Snapshot: Anatomic Pathology Testing Market

The Anatomic Pathology Testing Market is experiencing steady expansion, driven by the robust uptake of digital pathology and molecular diagnostics. From 2025 to 2032, the market is projected to grow from USD 47.92 billion to USD 75.01 billion, reflecting a compound annual growth rate (CAGR) of 6.60%. Drivers fueling this momentum include increased investment in laboratory infrastructure, adoption of scalable digital platforms, and broader application of advanced testing methods worldwide. Healthcare providers are prioritizing modernization initiatives, leading to accelerated integration of technology across established and emerging regions. These trends signal sustained demand for enhanced diagnostic solutions and innovative operational models.

Scope & Segmentation

  • Test Types: Digital pathology platforms, such as slide scanners and image analysis software, expand the reach of traditional staining methods and incorporate immunohistochemistry, next-generation sequencing, and comprehensive molecular diagnostics.
  • Sample Classes: Cytology specimens, tissue biopsies, and frozen sections each require tailored pre-analytical steps to ensure specimen integrity, validation accuracy, and smooth downstream processing, impacting both diagnostic precision and workflow management.
  • Application Areas: Tests address genetic disorders at both chromosomal and molecular levels, support diagnosis of infectious diseases with bacterial or viral origins, and enable oncology solutions across organ-specific pathways, including breast, lung, and prostate cancer analysis.
  • End Users: Diagnostic laboratories, hospitals, and research institutions seek different benefits, from efficiency and seamless integration to adaptation of laboratory assay technologies for clinical or investigational objectives.
  • Regional Coverage: The Americas, EMEA (Europe, Middle East, and Africa), and Asia-Pacific are key markets, each shaped by unique regulatory standards, varying infrastructure requirements, and localized partnership models that guide technological and commercial adoption.
  • Technology Modalities: Digital solutions, immunochemistry reagents, modern molecular platforms, and integrated workflow tools support scalable operations and enable cross-platform compatibility in laboratories worldwide.

Key Takeaways for Senior Decision-Makers

  • Deployment of digital pathology now supports interoperable reviews and collaborative diagnostics, improving accuracy and continuity across distributed clinical networks.
  • Integration of molecular and traditional approaches provides more comprehensive disease characterization, bridging morphologic and genetic insights for better clinical decisions.
  • Strategic partnerships, including centralized laboratory networks and R&D collaborations, accelerate the introduction of novel assays and expand the potential of translational diagnostics.
  • Vendors are innovating by delivering validated, interoperable systems and simplifying technology acquisition through clear contract and integration pathways for clinical and research buyers.
  • Organizations must adapt to distinct regional realities, requiring flexible deployment plans and ongoing resource alignment to maximize market presence and operational efficiency.

Tariff Impact on Procurement and Operations

Current U.S. tariff policies are reshaping procurement and operational strategies. Senior procurement leaders are responding to these shifts by broadening their supplier base, employing longer-term agreements, and focusing on regional distribution solutions. These actions help maintain supply continuity and reduce the risks of service disruption, even amid changing market conditions and increased cost sensitivity for pathology equipment and consumables.

Methodology & Data Sources

This analysis is based on triangulated evidence from peer-reviewed scientific sources, regulatory guidelines, device validation findings, and direct insights from clinical professionals. Recommendations are founded on rigorous cross-verification of device performance, user experience, and independent technical assessments.

The Anatomic Pathology Testing Market: Why This Report Matters

  • Enables decision-makers to align procurement and technology deployment with regulatory shifts and evolving operational goals.
  • Guides laboratory teams toward improved diagnostic accuracy, robust supply chains, and practical pathways for technology adoption.
  • Offers a reliable resource for planning capital expenditure, pursuing partnerships, and building organizational strength in the anatomic pathology sector.

Conclusion

The anatomic pathology testing market is advancing through digital transformation, molecular technology, and adaptive workflows. Leaders prepared to synchronize systems and embrace innovation will be optimally positioned to meet complex clinical and operational challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Anatomic Pathology Testing Market, by Test Type
8.1. Digital Pathology
8.1.1. Image Analysis Software
8.1.2. Slide Scanners
8.2. Hematoxylin And Eosin Staining
8.3. Immunohistochemistry
8.3.1. Monoclonal Antibody
8.3.2. Polyclonal Antibody
8.4. Molecular Pathology
8.4.1. Fluorescence In Situ Hybridization
8.4.2. Next Generation Sequencing
8.4.3. Polymerase Chain Reaction
8.5. Special Staining
8.5.1. Periodic Acid-Schiff Stain
8.5.2. Silver Stain
8.5.3. Trichrome Stain
9. Anatomic Pathology Testing Market, by Sample Type
9.1. Cytology Samples
9.2. Frozen Sections
9.3. Tissue Biopsy
10. Anatomic Pathology Testing Market, by Application
10.1. Genetic Disorders
10.1.1. Chromosomal Disorders
10.1.2. Single Gene Disorders
10.2. Infectious Diseases
10.2.1. Bacterial Infections
10.2.2. Viral Infections
10.3. Oncology
10.3.1. Breast Cancer
10.3.2. Lung Cancer
10.3.3. Prostate Cancer
11. Anatomic Pathology Testing Market, by End User
11.1. Diagnostic Laboratories
11.2. Hospitals
11.3. Research Institutes
12. Anatomic Pathology Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Anatomic Pathology Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Anatomic Pathology Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Anatomic Pathology Testing Market
16. China Anatomic Pathology Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Abcam plc
17.7. Agilent Technologies Inc.
17.8. Becton, Dickinson and Company
17.9. BioGenex Laboratories Inc.
17.10. Bio SB Inc.
17.11. Danaher Corporation
17.12. Eurofins Scientific SE
17.13. F. Hoffmann-La Roche AG
17.14. Hamamatsu Photonics K.K.
17.15. Hologic Inc.
17.16. Indica Labs LLC
17.17. Laboratory Corporation of America Holdings
17.18. Leica Biosystems
17.19. Merck KGaA
17.20. NeoGenomics Laboratories Inc.
17.21. PerkinElmer Inc.
17.22. Philips Healthcare
17.23. Qiagen N.V.
17.24. Quest Diagnostics Incorporated
17.25. Sakura Finetek USA Inc.
17.26. Sonic Healthcare Limited
17.27. Synlab Holding GmbH
17.28. Sysmex Corporation
17.29. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SLIDE SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SLIDE SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HEMATOXYLIN AND EOSIN STAINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HEMATOXYLIN AND EOSIN STAINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HEMATOXYLIN AND EOSIN STAINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PERIODIC ACID-SCHIFF STAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PERIODIC ACID-SCHIFF STAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PERIODIC ACID-SCHIFF STAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SILVER STAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SILVER STAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SILVER STAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TRICHROME STAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TRICHROME STAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TRICHROME STAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CYTOLOGY SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CYTOLOGY SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CYTOLOGY SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FROZEN SECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FROZEN SECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FROZEN SECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 158. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 161. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 165. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 181. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 182. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 184. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 185. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 186. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 188. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 189. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 190. AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 207. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 209. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 210. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 211. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 213. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 214. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 215. ASEAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 218. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 219. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 220. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 221. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 222. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 223. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 225. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 226. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 227. GCC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 242. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 243. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 244. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 245. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 246. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 247. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 249. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 250. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 251. BRICS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 254. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 255. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 256. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 257. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 258. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 259. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 261. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 262. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 263. G7 ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 266. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 267. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 268. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 269. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 270. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 271. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 273. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 274. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 275. NATO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 290. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 291. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 292. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2032 (USD MILLION)
TABLE 293. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 294. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2032 (USD MILLION)
TABLE 295. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 296. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 297. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 298. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 299. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 300. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Anatomic Pathology Testing market report include:
  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • BioGenex Laboratories Inc.
  • Bio SB Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Hamamatsu Photonics K.K.
  • Hologic Inc.
  • Indica Labs LLC
  • Laboratory Corporation of America Holdings
  • Leica Biosystems
  • Merck KGaA
  • NeoGenomics Laboratories Inc.
  • PerkinElmer Inc.
  • Philips Healthcare
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Sakura Finetek USA Inc.
  • Sonic Healthcare Limited
  • Synlab Holding GmbH
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 51 Billion
Forecasted Market Value ( USD ) by 2032 $ 75.01 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Anatomic Pathology Market - Global Forecast 2026-2032 - Product Image

Anatomic Pathology Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Anatomic Pathology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Anatomic Pathology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 110 Pages
  • Global
From
Anatomic Pathology Market - Products and Applications - Product Image

Anatomic Pathology Market - Products and Applications

  • Report
  • 256 Pages
  • Global
From
Anatomic Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Anatomic Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Anatomic Pathology Equipment and Consumables Market Report 2025 - Product Image

Anatomic Pathology Equipment and Consumables Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.